insights_auto
Outlook: 75.0% bullish·1.6% bearish
Go to analysischevron_right
ABBV:NYSE
AbbVie Common Stock
$276.47
arrow_upward
+1.49%(+4.05) 1D
$276.43
arrow_downward
-0.01% (-0.040)bedtimeAfter hours
Closed: Oct 9, 4:01:20 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABBV...
Open
$271.53
High
$277.60
Low
$270.38
Mkt. cap
488.55B
Avg. vol.
4.42M
Volume
4.30M
Dividend
2.50%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
78.19
52-wk high
$277.60
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
Open
$271.53
High
$277.60
Low
$270.38
Mkt. cap
488.55B
Avg. vol.
4.42M
Volume
4.30M
Dividend
2.50%
Quarterly dividend
$1.73
Ex-dividend date
Oct 15, 2026
P/E ratio
78.19
52-wk high
$277.60
52-wk low
$190.75
EPS
$3.54
Beta
0.23
Shares outstanding
1.77B
No. of employees
57K
News stories
From web sources and news partners
The Globe and Mail
·
1 hour ago
AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.
The Globe and Mail
·
21 hours ago
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Alkermes (ALKS)
Yahoo! Finance Canada
·
1 day ago
What Does AbbVie (ABBV) Winning Two FDA Breakthrough Tags Mean For Its Oncology Pipeline?
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com